Welcome to the Damora Therapeutics 2026 Annual Meeting of Stockholders. Please note that in order to vote and/or submit a question at this meeting, you must enter the meeting as a shareholder by entering your unique 16-digit control number. I will now turn the meeting over to Jennifer Jarrett, Chief Executive Officer and member of the board of Damora. Good morning. I'm Jennifer Jarrett, Chief Executive Officer and member of the board of Damora. On behalf of our entire board and management team, it is my pleasure to welcome all of you. It is just after 9:00 A.M. Eastern Time, I call to order the Damora Annual Stockholders' Meeting. Joining me on the call are Garrett Winslow, our General Counsel and Corporate Secretary. Mr. Winslow will serve as Secretary for this meeting. A representative of our external auditor, Ernst & Young, is also available for questions. You may vote your shares online at any time during this meeting prior to the closing of the polls. The polls opened at the beginning of the meeting for voting on the matters to be presented. The polls will close immediately after the presentation and discussion of the matters to be voted on today. If you have any questions related to the proposals, please submit them now or throughout the meeting to the virtual meeting portal. We will now proceed with the formal business of the meeting as set forth in the meeting notice. By entering the virtual meeting, you should have access to the agenda and rules of conduct, which will govern this meeting and any question and answer portion of this meeting. If you have a question pertaining to the proposals, please submit it electronically. The Damora board set April 22nd, 2026, as the record date for this meeting. Only stockholders of record on that date are entitled to vote at this meeting. I hereby confirm that notice of this meeting has been duly given, and the proxy materials and 2025 annual reports were made available to all stockholders as of April 29th, 2026. I'm also confirming that a list of stockholders entitled to vote at this meeting has been available and is currently available on the virtual annual meeting page that you are currently viewing. Francis H. Bird, a representative of the Cardea Group, has been appointed as our Inspector of Election in the tabulation of proxies and voting. I have received an oath signed by the Inspector of Election, stating that they will faithfully execute with strict impartiality their duties. As of the record date, there were 60,300,212 shares of the company's common stock issued and outstanding, each entitled to one vote. I have been informed by our Inspector of Election that proxies have been received for approximately $55 million out of the approximately $60.3 million shares of our common stock outstanding on the record date, representing approximately 91.2% of our then outstanding common stock. As this constitutes quorum, I declare this meeting is properly constituted and convened. A copy of the notices, the annual meeting proxy materials, the affidavits of mailing, the stockholder list, and the oath of the Inspector of Election will be incorporated into the minutes of this meeting. On behalf of Damora, I would like to express my appreciation to all stockholders who returned their proxies. Garrett, can you please review the proposals? Thank you, Jen. Each proposal is described in the annual meeting proxy materials, and the board recommends a vote in favor of each of these proposals, except with respect to proposal three, on which the board recommends a vote for one year. The first item of business is the election of two directors to serve until the 2029 annual meeting of stockholders or until their respective successor is elected and qualified, or until their earlier resignation or removal. The nominees for director are Michael Landsittel and Dr. Cameron Turtle, and details on their backgrounds are disclosed in the proxy statement for this meeting. Damora has an advanced notice bylaw provision that requires advanced notice of stockholder nominations. As such, the nominations are closed. If you have any questions regarding this proposal, please submit them electronically now. The second item to be considered is an advisory vote on the compensation of the company's named executives. The board recommends a vote for this proposal. If you have any questions related to this proposal, please enter them electronically now. The third item to be considered is an advisory vote on the frequency of future advisory votes to approve the compensation paid to Damora's named executive officers. Stockholders may vote to hold such advisory votes every one year, two years, or three years. The board recommends a vote for one year as the frequency for future advisory votes on executive compensation. If you have any questions related to this vote, please submit them now. The fourth item to be considered is the ratification of the selection of Ernst & Young LLP as the company's independent registered public accounting firm for the fiscal year ending December 31st, 2026. The board recommends a vote for this proposal. That was the final proposal for today's meeting. If you have any questions or would like any discussion related to these proposals, please submit them now. I will now pause for 15 seconds. Okay. As I see no questions on the proposals, we'll close the polls shortly. If you have already voted by proxy, you need not vote today unless you would like to change your vote. Any stockholder who hasn't yet voted or wishes to change their vote may do so by clicking on the voting button on the web portal and following the instructions there. Since everyone has had the opportunity to vote, I declare the polls now closed, and I will report the results of the voting based on the unofficial results. On a preliminary basis, the votes have been counted. Based on the preliminary vote tabulation, the director nominees, Michael Landsittel and Dr. Cameron Turtle, are elected as Class III members of Damora's Board of Directors. The advisory say on pay proposal is approved. One year is the frequency selected by stockholders for future advisory votes on executive compensation, and the selection of Ernst & Young LLP as the company's independent registered public accounting firm for the fiscal year ending December 31st, 2026, is ratified. We will publish a full tally of the votes on a current report on Form 8-K to be filed with the SEC, and a certified final Inspector of Election report will be prepared and filed with the official minutes of the meeting. This concludes the formal portion of today's meeting. The meeting is now adjourned. Thank you all for joining us today. Ladies and gentlemen, this concludes today's meeting. Thank you for joining. You may now disconnect.